AbbVie
ABBV
#35
Rank
$276.02 B
Marketcap
$156.31
Share price
0.98%
Change (1 day)
14.56%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total debt

Total debt on the balance sheet as of March 2024 : $74.00 B

According to AbbVie's latest financial reports the company's total debt is $74.00 B. A companyโ€™s total debt is the sum of all current and non-current debts.

AbbVie - Total debt on balance sheet (from 2011 to 2024)

Total debt by year

Year Total debt Change
2023-12-31$59.38 B-6.14%
2022-12-31$63.27 B-17.49%
2021-12-31$76.68 B-10.89%
2020-12-31$86.05 B28.97%
2019-12-31$66.72 B65.54%
2018-12-31$40.31 B7.87%
2017-12-31$37.36 B1.43%
2016-12-31$36.84 B16.33%
2015-12-31$31.67 B111.46%
2014-12-31$14.97 B1.73%
2013-12-31$14.72 B-6.06%
2012-12-31$15.67 B32550%
2011-12-31$48 M

Total debt for similar companies or competitors

Company Total debt differencediff. Country
$68.70 B-7.15%๐Ÿ‡บ๐Ÿ‡ธ USA
$26.21 B-64.58%๐Ÿ‡บ๐Ÿ‡ธ USA
$64.02 B-13.49%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.94 B-90.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$25.19 B-65.95%๐Ÿ‡บ๐Ÿ‡ธ USA
$57.40 B-22.42%๐Ÿ‡บ๐Ÿ‡ธ USA
$34.55 B-53.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
$22.45 B-69.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
$0.51 B-99.31%๐Ÿ‡บ๐Ÿ‡ธ USA